knowledge -WSS

knowledge

author：focus 2025-10-01 17:21:07 - browse：68952

The human gut teems with bacteria and other colorful microbes. — NIH

One of the indignities of getting older is the way your body’s defenses against microbes begin to break down, leaving you extra vulnerable to infection. Researchers studying the ways these systems change with age refer to them collectively as “immunosenescence,” or, more poetically, the “twilight of immunity.” But even as scientific understanding of the phenomenon has grown over the past decade, the forces driving it remain murky.

One theory is that it all starts in the bone marrow, where a primitive reserve of stem cells replenishes the ranks of blood and immune cells to the tune of about 500 billion new cells every day. Some of these hematopoietic stem cells, or HSCs, are more likely to become long-lived stewards of immune memory like B cells and T cells; others are more likely to give rise to blood cells and front-line immune defenders. They all work in concert to get the balance right. As people age, though, one lineage of HSCs starts to dominate, throwing the equilibrium off-kilter.

On Wednesday, a team of scientists at Stanford University and the National Institutes of Health Rocky Mountain Laboratories reported in Nature that this age-associated imbalance in HSCs is to blame for a cascade of downstream declines in immune function. And by restoring a youthful balance of these cells with injections of antibodies, they were able to rejuvenate the immune systems of older mice — enabling them to better fend off viral attacks.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Medicare Advantage enrollment grows 7.1% to 33.4 million people

leisure time

WSS

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Hospitals are piloting generative AI tools as regulators play catch

Takeda, Janssen join wearable maker to measure scratching

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Medicare Advantage enrollment hits roughly 33.4 million

BIO selects John Crowley as new CEO

leisure time

knowledge

leisure time

Medicare proposal to cover medical devices draws a mixed reaction

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

The high cost of giving birth even with insurance

Flagship Pioneering startup Sonata Therapeutics lays off 21

How to save PrEP access — and even expand it

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

At least 13 dead in Texas as scorching temps continue

With clinical trial data readouts, here's how to spot spin

Medical records are filled with copy

As biotech industry slumps, bioscience job market is upside down

focus

Pediatric cancer treatments threatened by a new FDA policy

FDA warns medical device makers about rise in fabricated data

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Mayo Clinic plans $5B tech

As AI regulations shape up, health tech startups beg for clarity

focus

leisure time

Wikipedia

explore